Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Idolazzi

Showing results (11-20 of 32) with videos related to

Pageof 4
Sort By:
Reumatismo|July 30, 2014
Vitamin D and rheumatic diseasesM Rossini, D Gatti, O Viapiana, et al.
Reumatismo|September 10, 2016
The negative bone effects of the disease and of chronic corticosteroid treatment in premenopausal women affected by rheumatoid arthritisA Fassio, L Idolazzi, M A Jaber, et al.
Bone|July 8, 2017
Treatment with neridronate in children and adolescents with osteogenesis imperfecta: Data from open-label, not controlled, three-year Italian studyL Idolazzi, A Fassio, O Viapiana, et al.
Reumatismo|April 2, 2015
Why golimumab in the treatment of psoriatic arthritis, ankylosing spondylitis and rheumatoid arthritis?M Rossini, O Viapiana, G Orsolini, et al.
The British Journal of Dermatology|October 22, 2011
Vitamin D status in patients with chronic plaque psoriasisP Gisondi, M Rossini, A Di Cesare, et al.
Calcified Tissue International|January 29, 2017
Long-term Effects of Neridronate in Adults with Osteogenesis Imperfecta: An Observational Three-Year Italian StudyO Viapiana, L Idolazzi, A Fassio, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|June 3, 2016
Teriparatide and denosumab combination therapy and skeletal metabolismL Idolazzi, M Rossini, O Viapiana, et al.
European Journal of Internal Medicine|December 13, 2016
Periostin: The bone and beyondL Idolazzi, E Ridolo, A Fassio, et al.
Reumatismo|September 22, 2017
Effects of secukinumab on serum adipocytokines: preliminary dataA Fassio, D Gatti, P Gisondi, et al.
Reumatismo|May 8, 2023
Secukinumab retention rate is greater in patients with psoriatic arthritis presenting with axial involvementG Adami, L Idolazzi, C Benini, et al.
Pageof 4

Showing results (11-20 of 32) with videos related to

Sort By:
Pageof 4
Reumatismo|July 30, 2014
Vitamin D and rheumatic diseasesM Rossini, D Gatti, O Viapiana, et al.
Reumatismo|September 10, 2016
The negative bone effects of the disease and of chronic corticosteroid treatment in premenopausal women affected by rheumatoid arthritisA Fassio, L Idolazzi, M A Jaber, et al.
Bone|July 8, 2017
Treatment with neridronate in children and adolescents with osteogenesis imperfecta: Data from open-label, not controlled, three-year Italian studyL Idolazzi, A Fassio, O Viapiana, et al.
Reumatismo|April 2, 2015
Why golimumab in the treatment of psoriatic arthritis, ankylosing spondylitis and rheumatoid arthritis?M Rossini, O Viapiana, G Orsolini, et al.
The British Journal of Dermatology|October 22, 2011
Vitamin D status in patients with chronic plaque psoriasisP Gisondi, M Rossini, A Di Cesare, et al.
Calcified Tissue International|January 29, 2017
Long-term Effects of Neridronate in Adults with Osteogenesis Imperfecta: An Observational Three-Year Italian StudyO Viapiana, L Idolazzi, A Fassio, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|June 3, 2016
Teriparatide and denosumab combination therapy and skeletal metabolismL Idolazzi, M Rossini, O Viapiana, et al.
European Journal of Internal Medicine|December 13, 2016
Periostin: The bone and beyondL Idolazzi, E Ridolo, A Fassio, et al.
Reumatismo|September 22, 2017
Effects of secukinumab on serum adipocytokines: preliminary dataA Fassio, D Gatti, P Gisondi, et al.
Reumatismo|May 8, 2023
Secukinumab retention rate is greater in patients with psoriatic arthritis presenting with axial involvementG Adami, L Idolazzi, C Benini, et al.
Pageof 4